Par Health Appoints Dr. William Larkins as EVP and Chief Scientific Officer to Lead Sterile Injectables Par Health has named Dr. William Larkins as EVP and Chief Scientific Officer. His deep expertise in sterile injectables aims to drive company growth and innovation.

Par Health Appoints Dr. William Larkins as EVP and Chief Scientific Officer to Lead Sterile Injectables #United_States #St._Louis #Par_Health #sterile_injectables #Dr._Larkins

PAI Pharma's Strategic Acquisition of Nivagen Pharmaceuticals: A Milestone in Sterile Injectable Manufacturing PAI Pharma has acquired Nivagen Pharmaceuticals, enhancing domestic sterile injectable production and addressing critical drug shortages faced by U.S. hospitals.

PAI Pharma's Strategic Acquisition of Nivagen Pharmaceuticals: A Milestone in Sterile Injectable Manufacturing #United_States #Sacramento #PAI_Pharma #sterile_injectables #Nivagen_Pharmaceuticals

Simtra BioPharma Solutions Expands Global Manufacturing to Boost Sterile Injectables Production Simtra BioPharma Solutions is enhancing its manufacturing capabilities across North America and Europe to meet the rising demand for sterile injectables.

Simtra BioPharma Solutions Expands Global Manufacturing to Boost Sterile Injectables Production #USA #ADCs #sterile_injectables #Simtra_BioPharma_Solutions #Bloomington,_Indiana

Simtra BioPharma Solutions Expands Manufacturing Facility in Halle, Germany to Meet Global Demand Simtra BioPharma Solutions has completed a new production building in Halle, Germany, expanding its capacity to manufacture critical injectable therapeutics.

Simtra BioPharma Solutions Expands Manufacturing Facility in Halle, Germany to Meet Global Demand #Germany #Simtra_BioPharma #sterile_injectables #Halle_Germany #Halle